We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$23.6M
Cap. Flow
-$8.89M
Cap. Flow %
-7.77%
Top 10 Hldgs %
48.95%
Holding
74
New
18
Increased
7
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$3.16M
2
MRK icon
Merck
MRK
+$2.39M
3
SLTM
SOLTA MED INC (DE)
SLTM
+$2.02M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.95M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.3M

Top Sells

Rank Stock Value
1
ARAY icon
Accuray
ARAY
+$3.89M
2
CAH icon
Cardinal Health
CAH
+$3.3M
3
TECH icon
Bio-Techne
TECH
+$2.76M
4
OFIX icon
Orthofix Medical
OFIX
+$1.92M
5
HUM icon
Humana
HUM
+$1.84M

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.65%
2 Healthcare 43.35%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLTM
26
DELISTED
SOLTA MED INC (DE)
SLTM
$1.85M 1.62%
+892,250
New +$2.02M
AUXL
27
PUT
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$1.82M 1.59%
+100,000
New +$1.81M
AGN
28
DELISTED
Allergan plc
AGN
$1.8M 1.58%
12,524
– –
SNY icon
29
Sanofi
SNY
$107B
$1.66M 1.45%
32,735
– –
HNT
30
CALL
DELISTED
HEALTH NET INC
HNT
$1.58M 1.39%
+50,000
New +$1.58M
SGNT
31
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.51M 1.32%
73,822
-29,100
-28% -$648K
VVUS
32
PUT
DELISTED
Vivus Inc
VVUS
$1.4M 1.22%
15,000
+10,000
+200% +$1.25M
ELV icon
33
Elevance Health
ELV
$86.6B
$1.25M 1.1%
15,000
-7,638
-34% -$655K
GYRE icon
34
Gyre Therapeutics
GYRE
$708M
$1.08M 0.94%
+257
New +$1.03M
PCRX icon
35
Pacira BioSciences
PCRX
$1.03B
$986K 0.86%
20,500
-24,500
-54% -$893K
MDCO
36
CALL
DELISTED
Medicines Co
MDCO
$838K 0.73%
+25,000
New +$796K
AORT icon
37
Artivion
AORT
$1.3B
$828K 0.72%
118,288
– –
VXRT
38
DELISTED
Vaxart
VXRT
$758K 0.66%
+16,475
New +$714K
STML
39
DELISTED
Stemline Therapeutics, Inc.
STML
$746K 0.65%
+16,464
New +$537K
NBIX icon
40
Neurocrine Biosciences
NBIX
$15.8B
$566K 0.49%
+50,000
New +$687K
ZGNX
41
DELISTED
Zogenix, Inc.
ZGNX
$511K 0.45%
34,542
– –
CYTK icon
42
Cytokinetics
CYTK
$10.8B
$429K 0.38%
56,666
-10,000
-15% -$107K
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$413K 0.36%
396
– –
ANAC
44
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$401K 0.35%
37,730
– –
TCRT icon
45
Alaunos Therapeutics
TCRT
$4.22M
$394K 0.34%
667
– –
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
$313K 0.27%
+135,000
New +$339K
ACHN
47
DELISTED
Achillion Pharmaceuticals
ACHN
$302K 0.26%
+100,000
New +$685K
XNPT
48
CALL
DELISTED
XENOPORT, INC.
XNPT
$284K 0.25%
+50,000
New +$261K
AORT icon
49
CALL
Artivion
AORT
$1.3B
$279K 0.24%
39,900
– –
QLTI
50
CALL
DELISTED
QLT Inc
QLTI
$76K 0.07%
+16,500
New +$71.6K
1
2
3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Healthcare Value Capital held 74 positions worth $114M, down 17% from $138M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Healthcare Value Capital withdrew a net $8.89M in Q3 2013, closing 24 positions and reducing 11 holdings. Its most notable exit was Accuray, an estimated $3.89M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 60% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Healthcare Value Capital opened a new position in HEALTH NET INC worth $3.17M.

  • Healthcare Value Capital's largest Q3 2013 buy was HEALTH NET INC: 100,000 shares worth $3.17M.
  • Healthcare Value Capital added most to Merck in Q3 2013, an estimated $2.39M increase.
  • Healthcare Value Capital's biggest Q3 2013 reduction was Humana, cutting an estimated $1.84M.
  • Healthcare Value Capital fully exited Accuray in Q3 2013, selling an estimated $3.89M.
  • Healthcare Value Capital's ten largest holdings make up 49% of its $114M portfolio in Q3 2013.
  • Healthcare Value Capital opened 18 new positions and closed 24 in Q3 2013.
  • Healthcare Value Capital's portfolio value fell 17% quarter-over-quarter to $114M.

Based on Healthcare Value Capital's 13F filing for Q3 2013, filed 5 Nov 2013.